LFMD News

LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm

LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk

SHAREHOLDER ALERT: Berger Montague Reminds LifeMD, Inc. (NASDAQ: LFMD) Investors of Class Action Lawsuit Deadline

Investors in LifeMD, Inc. Should Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights - LFMD

LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 25, 2025 in LifeMD, Inc. Lawsuit - LFMD

LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Shareholders that lost money on LifeMD, Inc.(LFMD) should contact The Gross Law Firm about pending Class Action - LFMD

LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference